SSA
BLU

Schonfeld Strategic Advisors’s BELLUS Health Inc. BLU Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-222,956
Closed -$1.53M – 3202
2022
Q1 		$1.53M Sell
222,956
-94,192
-30% -$607K 0.01% 827
2021
Q4 		$2.55M Buy
317,148
+107,377
+51% +$713K 0.02% 640
2021
Q3 		$1.29M Buy
+209,771
New +$795K 0.01% 866
2021
Q1 		– Sell
-16,400
Closed -$49K – 2217
2020
Q4 		$49K Buy
+16,400
New +$44.4K ﹤0.01% 1498
2020
Q1 		– Sell
-162,252
Closed -$1.23M – 1627
2019
Q4 		$1.23M Sell
162,252
-7,700
-5% -$52.6K 0.03% 455
2019
Q3 		$1.09M Buy
+169,952
New +$1.2M 0.03% 451

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Schonfeld Strategic Advisors's BLU Position: Q2 2022 in Review

Schonfeld Strategic Advisors sold out of BELLUS Health Inc. (BLU) in Q2 2022, closing a stake of 222,956 shares — an estimated $1.53M sold.

Schonfeld Strategic Advisors first reported a position in BLU in Q3 2019 and held it in 6 quarters. The position peaked at $2.55M in Q4 2021. 94 funds tracked by Wall St. Rank hold BLU as of Q2 2022.

  • Schonfeld Strategic Advisors reported no remaining BELLUS Health Inc. position as of Q2 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 222,956 BELLUS Health Inc. shares in Q2 2022, an estimated $1.53M.
  • Schonfeld Strategic Advisors first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's BELLUS Health Inc. position peaked at $2.55M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.